Pioneering the next generation of pulmonary medicine and microbiome science

Changes in microbial signatures of the lungs and airways are associated with worsening chronic respiratory disease and persistent inflammation. As such, Alveolus Bio is focused on harnessing the anti-inflammatory power of commensal bacteria strains and their byproducts for inhaled delivery straight to the target tissue: the lungs.

Origin Story

Alveolus Bio began in Dr. Vivek Lal’s Pulmonary Microbiome Lab and Dr. Amit Gaggar’s Program in Lung Protease and Matrix Biology at the University of Alabama at Birmingham (UAB).

The collaborating scientists published groundbreaking research on the neonatal lung microbiome, and became one of the first to conduct gain and loss of function studies on underlying mechanisms of neutraphillic inflammation and the extracellular matrix of the lung.

Scientific Team

Alveolus Bio’s scientific team and advisors have expertise across a spectrum of chronic respiratory diseases from Bronchopulmonary Dysplasia, to Cystic Fibrosis, to Chronic Obstructive Pulmonary Disease.

C Vivek Lal MD FAAP

C Vivek Lal MD FAAP

Founder & CEO

Amit Gaggar MD PhD

Amit Gaggar MD PhD

Chief Medical Officer

Theodora Nicola MD PhD MBA

Theodora Nicola MD PhD MBA

Lead Scientist

Yvonne Huang MD

Yvonne Huang MD

Science Advisor, Microbiome and Adult Lung Disease

Nancy Wenger

Nancy Wenger

Research and Development Manager

Nirmal Sharma MD

Nirmal Sharma MD

Science Advisor, Lung Transplant

Scientific Team

Alveolus Bio’s scientific team and advisors have expertise across a spectrum of chronic respiratory diseases from Bronchopulmonary Dysplasia, to Cystic Fibrosis, to Chronic Obstructive Pulmonary Disease.

Namasivayam Ambalavanan MD

Namasivayam Ambalavanan MD

Science Advisor, Pediatric Lung Disease

Casey Morrow PhD

Casey Morrow PhD

Science Advisor, Microbiome

Mike Wells MD PhD

Mike Wells MD PhD

Science Advisor, Clinical Trials and Adult Lung Disease

Research Infrastructure

At the heart of Alveolus Bio is world class infrastructure and personnel to support in vivo and in vitro models of various respiratory diseases.

Alveolus Bio serves as a platform for respiratory drug development from discovery to clinical trials.

Publications